Corvus Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
552
across all filing types
Latest filing
2026-05-14
Regulatory Filings
Country
US
United States of America
Listing
US
CRVS
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for immune diseases and cancer. The company focuses on pioneering ITK (Interleukin-2-inducible T-cell kinase) inhibition as a new approach to modulate and control signaling pathways within the immune system. Its lead product candidate, soquelitinib, is a first-in-class, oral therapy that selectively inhibits ITK and is being developed for the treatment of T-cell lymphomas and other immune-related conditions. Corvus is advancing a pipeline of clinical-stage programs with differentiated mechanisms of action designed to precisely target critical immune pathways.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-14 | English | |
| S-8 - Corvus Pharmaceuticals, Inc. (0001626971) (Filer) | 2026-05-07 | English | |
| SCHEDULE 13G/A - Corvus Pharmaceuticals, Inc. (0001626971) (Subject) | 2026-03-26 | English | |
| SCHEDULE 13D/A Filing | 2026-02-05 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 45960842 | FORM 8-K | 2026-05-14 | English | ||
| 43561460 | S-8 - Corvus Pharmaceuticals, Inc. (0001626971) (Filer) | 2026-05-07 | English | ||
| 33052635 | SCHEDULE 13G/A - Corvus Pharmaceuticals, Inc. (0001626971) (Subject) | 2026-03-26 | English | ||
| 30997765 | SCHEDULE 13D/A Filing | 2026-02-05 | English | ||
| 30997779 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 30997753 | 4 Filing | 2026-01-30 | English | ||
| 30997774 | SCHEDULE 13D/A Filing | 2026-01-27 | English | ||
| 30997800 | 8-K Filing | 2026-01-23 | English | ||
| 30997711 | 424B5 Filing | 2026-01-23 | English | ||
| 30997843 | 8-K Filing | 2026-01-20 | English | ||
| 30997827 | 424B5 Filing | 2026-01-20 | English | ||
| 30997749 | 8-K Filing | 2026-01-20 | English | ||
|
2025
3 filings
| |||||
| 12834839 | Director's Dealing 2025 | 2025-12-08 | English | ||
| 12834840 | Director's Dealing 2025 | 2025-12-08 | English | ||
| 12834841 | Director's Dealing 2025 | 2025-12-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
|
ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therape…
|
AVXL | US | Manufacturing |
|
Anbio Biotechnology
Develops and provides in-vitro diagnostic (IVD) solutions a…
|
NNNN | KY | Manufacturing |
|
Anebulo Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for acute canna…
|
ANEB | US | Manufacturing |
|
AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide…
|
4563 | JP | Manufacturing |
|
ANG Lifesciences India Limited
Develops and manufactures sterile dry powder and liquid inj…
|
540694 | IN | Manufacturing |
|
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.
Develops biopharmaceuticals, genetic engineering products, …
|
300009 | CN | Manufacturing |
Corvus Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32755/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32755 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32755 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32755 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32755}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Corvus Pharmaceuticals, Inc. (id: 32755)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.